ArticleCureus2025
Choroidal Osteoma Complicated by Choroidal Neovascularization: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Use of Aflibercept to Treat Choroidal Neovascularization Secondary to Choroidal Osteoma in a 7-Year-Old Child: A Multimodal Imaging Case Report.Case reports in ophthalmological medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 13-year-old girl with no prior systemic or ocular comorbidities presented to the eye clinic at Shifa International Hospital, Islamabad, Pakistan, with complaints of blurred vision in her left eye. Fundus examination revealed a well-defined, yellow-orange lesion at the posterior pole. B-scan ultrasonography demonstrated an echo-dense lesion, most prominent at low gain, while swept source optical coherence tomography (SS-OCT) showed a hyperreflective choroidal mass with associated subretinal fluid (SRF). Based on these findings, a diagnosis of choroidal osteoma complicated by choroidal neovascularization (CNV) was established. This case report describes the management of a pediatric case of CNV related to choroidal osteoma with a series of intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections over nine months, resulting in significant regression of CNV and a reduction in SRF. She continues to be monitored with multimodal imaging and intermittent therapy, demonstrating favorable anatomical and functional outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.